ABGENIX INC
10-Q, EX-27.1, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ABGENIX INC, 10-Q, EX-10.56, 2000-08-14
Next: HORIZON MEDICAL PRODUCTS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED BALANCE SHEETS AND THE STATEMENTS OF OPERATIONS AS OF AND FOR THE
THREE MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         124,546
<SECURITIES>                                   430,991
<RECEIVABLES>                                      600
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               570,770
<PP&E>                                          10,148
<DEPRECIATION>                                   3,894
<TOTAL-ASSETS>                                 654,666
<CURRENT-LIABILITIES>                           19,145
<BONDS>                                             33
                                0
                                          0
<COMMON>                                       681,715
<OTHER-SE>                                    (46,434)
<TOTAL-LIABILITY-AND-EQUITY>                   654,666
<SALES>                                              0
<TOTAL-REVENUES>                                 3,478
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                14,494
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 185
<INCOME-PRETAX>                                (2,420)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,420)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,420)
<EPS-BASIC>                                      (.03)
<EPS-DILUTED>                                    (.03)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission